Influence of concurrent mutations on overall survival in EGFR-mutated non-small cell lung cancer
M Chevallier, P Tsantoulis, A Addeo… - Cancer genomics & …, 2020 - cgp.iiarjournals.org
Background/Aim: Non-small cell lung cancer (NSCLC) patients with activating somatic
mutations in the epidermal growth factor receptor (EGFR) have better outcomes with tyrosine …
mutations in the epidermal growth factor receptor (EGFR) have better outcomes with tyrosine …
Influence of Concurrent Mutations on Overall Survival in EGFR-mutated Non-small Cell Lung Cancer.
M CHEVALLIER, P TSANTOULIS… - Cancer Genomics & …, 2020 - search.ebscohost.com
Abstract Background/Aim: Non-small cell lung cancer (NSCLC) patients with activating
somatic mutations in the epidermal growth factor receptor (EGFR) have better outcomes with …
somatic mutations in the epidermal growth factor receptor (EGFR) have better outcomes with …
[HTML][HTML] Influence of Concurrent Mutations on Overall Survival in EGFR-mutated Non-small Cell Lung Cancer
M CHEVALLIER, P TSANTOULIS… - Cancer Genomics & …, 2020 - ncbi.nlm.nih.gov
Background/Aim: Non-small cell lung cancer (NSCLC) patients with activating somatic
mutations in the epidermal growth factor receptor (EGFR) have better outcomes with tyrosine …
mutations in the epidermal growth factor receptor (EGFR) have better outcomes with tyrosine …
Influence of Concurrent Mutations on Overall Survival in EGFR-mutated Non-small Cell Lung Cancer.
M Chevallier, P Tsantoulis, A Addeo… - Cancer genomics & …, 2020 - sonar.ch
RESULTS Of the 42 patients with advanced NSCLC harboring EGFR mutations who
received TKIs in our center, 22 (52%) had no concurrent mutations, 15 (36%) had a non …
received TKIs in our center, 22 (52%) had no concurrent mutations, 15 (36%) had a non …
[PDF][PDF] Influence of Concurrent Mutations on Overall Survival in EGFR-mutated Non-small Cell Lung Cancer
M CHEVALLIER… - CANCER …, 2020 - access.archive-ouverte.unige.ch
Archive ouverte UNIGE Influence of Concurrent Mutations on Overall Survival in EGFR-mutated
Non-small Cell Lung Cancer Page 1 Archive ouverte UNIGE https://archive-ouverte.unige.ch …
Non-small Cell Lung Cancer Page 1 Archive ouverte UNIGE https://archive-ouverte.unige.ch …
Influence of Concurrent Mutations on Overall Survival in EGFR-mutated Non-small Cell Lung Cancer
M Chevallier, P Tsantoulis, A Addeo… - Cancer genomics …, 2020 - pubmed.ncbi.nlm.nih.gov
Background/aim Non-small cell lung cancer (NSCLC) patients with activating somatic
mutations in the epidermal growth factor receptor (EGFR) have better outcomes with tyrosine …
mutations in the epidermal growth factor receptor (EGFR) have better outcomes with tyrosine …
[PDF][PDF] Influence of Concurrent Mutations on Overall Survival in EGFR-mutated Non-small Cell Lung Cancer
M CHEVALLIER, P TSANTOULIS… - CANCER …, 2020 - cgp.iiarjournals.org
Influence of Concurrent Mutations on Overall Survival in EGFR-mutated Non-small Cell Lung
Cancer Page 1 Abstract. Background/Aim: Non-small cell lung cancer (NSCLC) patients with …
Cancer Page 1 Abstract. Background/Aim: Non-small cell lung cancer (NSCLC) patients with …
Influence of Concurrent Mutations on Overall Survival in EGFR-mutated Non-small Cell Lung Cancer.
M Chevallier, P Tsantoulis, A Addeo… - Cancer Genomics & …, 2020 - europepmc.org
Results Of the 42 patients with advanced NSCLC harboring EGFR mutations who received
TKIs in our center, 22 (52%) had no concurrent mutations, 15 (36%) had a non-pathogenic …
TKIs in our center, 22 (52%) had no concurrent mutations, 15 (36%) had a non-pathogenic …
[引用][C] Influence of Concurrent Mutations on Overall Survival in EGFR-mutated Non-small Cell Lung Cancer
M CHEVALLIER, P TSANTOULIS, A ADDEO… - Cancer Genomics …, 2020 - cir.nii.ac.jp
Influence of Concurrent Mutations on Overall Survival in EGFR-mutated Non-small Cell Lung
Cancer | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …
Cancer | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …
Influence of Concurrent Mutations on Overall Survival in EGFR-mutated Non-small Cell Lung Cancer.
M Chevallier, P Tsantoulis, A Addeo… - Cancer genomics & …, 2020 - folia.unifr.ch
RESULTS Of the 42 patients with advanced NSCLC harboring EGFR mutations who
received TKIs in our center, 22 (52%) had no concurrent mutations, 15 (36%) had a non …
received TKIs in our center, 22 (52%) had no concurrent mutations, 15 (36%) had a non …